Roche’s Questionable Agreement Of Tamiflu Data

Roche, a pharmaceutical company, failed to form a multi-advisory board that would have examined and allowed researchers access to its data. The company has announced that it will now work […]

The Continued Defense of Amgen Provisions

Despite the avid criticisms regarding the Amgen provisions that were mysteriously provided within the fiscal cliff deal, well-known political figures in the United States have continually defended the provision that […]

Merck’s Woes From Vytorin-Related Shareholder Suits

Merck & Co. and subsidiary Schering-Plough are facing more lawsuits relating to yet another one of the company’s products, this time Vytorin. The manufacturers responsible for the contraceptive vaginal ring […]

Nursing Homes Are Rated by the Government

The Centers for Medicare and Medicaid Services (“CMS”) rates nursing homes on a five-star system. The purpose of this system is to promote transparency in an industry that is not […]